• Takeda oncology vet drills down the ‘basics' at cell therapy startup; Sarepta promotes new R&D chief

    15 days ago - By San Diego Biotechnology

    Kathryn Corzo Kathryn Corzo - an oncology veteran and the program head behind Sanofi's multiple myeloma monoclonal antibody isatuximab - is now in the C-suite. The newest member at cell therapy player bit.bio as their COO, the longtime drug developer left Takeda...
    Read more ...